Почетна › Рак простате › Њујорк › New York City
Kliničke studije za Рак простате u gradu New York City, NY
Jedna studija za Рак простате traži učesnike na lokaciji u gradu New York City ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Тражи се учесникФаза 3
- Mount Sinai Union Square, New York
- Mount Sinai Chelsea, New York
- Mount Sinai West, New York
- и још 4
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Тражи се учесникФаза 1
- Yale New Haven Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Тражи се учесникФаза 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Тражи се учесник
- Integrated Medical Professionals, New York
WATER IV PCa (AS Sub-study)
Тражи се учесник
- Integrated Medical Professionals, PLLC, New York
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Тражи се учесникОпсервациона студија
- Memorial Sloan Kettering Cancer Center, New York
A Study of Changes to Prostate Procedures
Тражи се учесникФаза 3
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Тражи се учесникФаза 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- и још 2
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Тражи се учесникФаза 1
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Тражи се учесникФаза 2
- Mount Sinai Hospital, New York
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
Тражи се учесникФаза 1
- Langone Health at NYC University, NYU School of Medicine, New York
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Тражи се учесникФаза 1
- Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Тражи се учесникФаза 3
- Memorial Sloan Kettering Cancer Center, New York
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Тражи се учесник
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Тражи се учесникФаза 3
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
Тражи се учесникФаза 1
- Columbia University Medical Center, New York
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Тражи се учесникФаза 1
- Columbia University Medical Center, New York
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Тражи се учесникФаза 3
- Icahn School of Medicine at Mount Sinai ( Site 0009), New York
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Тражи се учесникФаза 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Precision-Based Genomics in Prostate Cancer
Тражи се учесникОпсервациона студија
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai Hospital, New York
- Weill Cornell Medicine, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 2
- Memorial Sloan Kettering Hospital, New York
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Тражи се учесникФаза 3
- Mount Sinai Union Square, New York
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- и још 2
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Тражи се учесникФаза 1/2
- Research Site, New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Research Site 107, New York
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Тражи се учесникФаза 1
- NYU Langone Health, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Тражи се учесникФаза 1
- New York Cancer & Blood Specialists, New York
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Тражи се учесникФаза 3
- Memorial Sloan Kettering Cancer Center, New York
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Тражи се учесникФаза 3
- Research Site, New York
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Тражи се учесникФаза 1
- Research Site, New York
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Тражи се учесникФаза 3
- Weill Cornell Medicine NY-Presb, New York
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Тражи се учесникФаза 1/2
- Research Site, New York
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Тражи се учесникФаза 3
- Research Site, New York
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Тражи се учесникФаза 3
- Evelyn H. Lauder Breast and Imaging Center (BAIC)., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
- Sidney Kimmel Center for Prostate and Urological Cancers - Memorial Sloan Kettering Cancer Center, New York
A Study of a New PET Scanner in People With Cancer
Тражи се учесникОпсервациона студија
- Memorial Sloan Kettering Cancer Center, New York
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Тражи се учесникФаза 3
- NYP/Weill Cornell Medical Center, New York
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
Тражи се учесникФаза 2
- Icahn School of Medicine at Mount Sinai, New York
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- Research Site, New York
- Research Site, New York
A Study of Mental Health Care in People With Cancer
Тражи се учесник
- Memorial Sloan Kettering Cancer Center, New York
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Тражи се учесник
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Тражи се учесникФаза 2/3
- Mount Sinai Hosp Med School, New York
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
Тражи се учесникФаза 3
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Тражи се учесникФаза 2
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Тражи се учесникОпсервациона студија
- Memorial Sloan Kettering Cancer Center, New York
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center, New York
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center, New York
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer
Тражи се учесник
- Memorial Sloan Kettering Cancer Center, New York
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Тражи се учесникФаза 3
- Mount Sinai Doctors Urology Faculty Practice, New York
Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer
Тражи се учесникФаза 2
- NYU Langone Health, New York
A Study of Tarlatamab for People With Prostate Cancer
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
Тражи се учесникОпсервациона студија
- NYU Langone Health, New York
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Тражи се учесникФаза 1/2
- Memorial Sloan-Kettering Cancer Center (Mskcc), New York
Radiation Therapy Approaches for People With Prostate Cancer
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
Тражи се учесникОпсервациона студија
- NYU Langone Health, New York
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Тражи се учесник
- Memorial Sloan Kettering Cancer Center, New York
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation
Тражи се учесникОпсервациона студија
- NYU Langone Health - Tisch Hospital, New York
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Investigative Site #103, New York
- Investigative Site #106, New York
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Тражи се учесникФаза 3
- Memorial Sloan Kettering Cancer Center, New York
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Тражи се учесникФаза 3
- Columbia University Herbert Irving Comphrensive Cancer Center, New York
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
Тражи се учесник
- NYU Langone Health, New York
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Тражи се учесникФаза 1
- Memorial Sloane Kettering Cancer Center, New York
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Тражи се учесникФаза 1/2
- Columbia University, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Тражи се учесникФаза 2
- VA New York Harbor Healthcare System, New York
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
Тражи се учесникФаза 1
- Weill Cornell Medicine New York Presbyterian, New York
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
Тражи се учесникОпсервациона студија
- Columbia University Irving Medical Center, New York
CUIMC Focal Therapy Registry
Тражи се учесникОпсервациона студија
- Columbia University Irving Medical Center, New York
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Тражи се учесникОпсервациона студија
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical Center, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Тражи се учесникФаза 1
- Columbia University Irving Medical Center, New York
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Тражи се учесник
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
Clinical Trial of Approaches to Prostate Cancer Surgery
Тражи се учесник
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Тражи се учесникФаза 1/2
- New York Presbyterian/Weill Cornell Medical Center, New York
- Columbia University Irving Cancer Center, New York
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Тражи се учесникФаза 3
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
Тражи се учесник
- The New York Proton Center, New York
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Тражи се учесник
- Memorial Sloan Kettering Cancer Center, New York
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Mechanisms of Resistance to PSMA Radioligand Therapy
Тражи се учесникОпсервациона студија
- Memorial Sloan Kettering, New York
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy
Тражи се учесник
- NYU Langone Health, New York
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Тражи се учесникФаза 1/2
- Research Site, New York
- Research Site, New York
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
Тражи се учесникФаза 2
- Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai, New York
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Тражи се учесникФаза 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Тражи се учесник
- Columbia University Irving Medical Center, New York
Two Fraction Prostate SBRT With DIL SIB
Тражи се учесникФаза 1
- NYCyberKnife at Perlmutter Cancer Center, New York
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
Тражи се учесникФаза 2
- NYU Langone Health, New York
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
Тражи се учесникФаза 2
- Weill Cornell Medicine, New York
Upright MRI for Prostate Cancer Screening
Тражи се учесникОпсервациона студија
- Icahn School of Medicine at Mount Sinai, New York
Ablative Therapy in the Management of Prostate Cancer
Тражи се учесникОпсервациона студија
- Weill Cornell Medicine, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, New York
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
Тражи се учесникФаза 3
- Mount Sinai Hospital, New York
Comprehensive Outcomes for After Cancer Health
Тражи се учесникЗдраве особе су добродошле
- Memorial Sloan Kettering Cancer Center, New York
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
Тражи се учесникОпсервациона студија
- Weill Cornell Medical College, New York
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
Тражи се учесникФаза 2
- Icahn School of Medicine at Mount Sinai (ISMMS), New York
Studije za Рак простате u drugim gradovima
- Houston, TX73 студија
- Los Angeles, CA64 студија
- Boston, MA56 студија
- Seattle, WA45 студија
- St. Louis, MO45 студија
- Chicago, IL45 студија
- Baltimore, MD45 студија
- San Francisco, CA44 студија
- Philadelphia, PA41 студија
- Nashville, TN40 студија
- Washington, DC39 студија
- Dallas, TX39 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Многи мијелом59 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
- Затајење срца51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.